544611 — Mahamaya Lifesciences Share Price
Last trade - 00:00- IN₹3.45bn
- IN₹4.09bn
- IN₹2.64bn
- 34
- 35
- 68
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.3 | ||
| Price to Tang. Book | 7.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.18 | ||
| EV to EBITDA | 14.93 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 39.95% | ||
| Return on Equity | 34.53% | ||
| Operating Margin | 8.58% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,135.06 | 899.13 | 1,370.76 | 1,615.71 | 2,641.49 | n/a | n/a | 23.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +4.09 | +37.17 | +43.58 | +138.61 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mahamaya Lifesciences Limited is an India-based company, which is engaged in providing agricultural crop protection solutions. The Company carries on the business of import, export, manufacturing, trading, marketing and consultancy of crop protection products, health care science, health care products and medicines. It specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies and multinational corporations (MNCs). The Company also manufactures and sells calcined petroleum coke. Its business areas are categorized into crop protection, household pesticides, plant nutrition, and specialty chemicals. Its brands include KISERU, KANSHUDO, MAYAPRID, MAYAMECTIN 50, MAYAMECTIN 19, GHARIAL 30 FS, MAYAIMIDA, SAMBO, MAYAIMIDA 305, MAYAFIP GR, MAYAFIP SC, GHARIAL 25, VOLENO 50, VOLENO CS 49, FIPRONIL, MAYAGIBB, MAYAMRIT GR, MAYAMRIT, and MAYARHIZA.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- September 30th, 2025
- Incorporated
- May 7th, 2002
- Public Since
- November 18th, 2025
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 23,405,000
- Address
- GURGAON, 122001
- Web
- https://www.mahamayalifesciences.com/
- Phone
- +91 1244301988
- Auditors
- N.Naresh & Co
Upcoming Events for 544611
Similar to 544611
3B Blackbio DX
Bombay Stock Exchange
3B Films
Bombay Stock Exchange
A-1
Bombay Stock Exchange
Add-Shop E-Retail
Bombay Stock Exchange
Advance Petrochemicals
Bombay Stock Exchange
FAQ
As of Today at 02:52 UTC, shares in Mahamaya Lifesciences are trading at IN₹133.00. This share price information is delayed by 15 minutes.
Shares in Mahamaya Lifesciences last closed at IN₹133.00 and the price had moved by over the past 365 days. In terms of relative price strength the Mahamaya Lifesciences share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreMahamaya Lifesciences does not currently pay a dividend.
Mahamaya Lifesciences does not currently pay a dividend.
Mahamaya Lifesciences does not currently pay a dividend.
To buy shares in Mahamaya Lifesciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹133.00, shares in Mahamaya Lifesciences had a market capitalisation of IN₹3.45bn.
Here are the trading details for Mahamaya Lifesciences:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 544611
Based on an overall assessment of its quality, value and momentum Mahamaya Lifesciences is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mahamaya Lifesciences. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹133.00, shares in Mahamaya Lifesciences were trading +10.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mahamaya Lifesciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹133.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Mahamaya Lifesciences' directors